Format

Send to

Choose Destination
Cancer Sci. 2016 Apr;107(4):521-7. doi: 10.1111/cas.12902. Epub 2016 Mar 28.

Burden of cancer associated with type 2 diabetes mellitus in Japan, 2010-2030.

Author information

1
AXA Department of Health and Human Security, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
2
Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
3
Department of Diabetes Research, National Center for Global Health and Medicine, Tokyo, Japan.
4
Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan.
5
Division of Surveillance, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.
6
Department of Endocrinology and Diabetes, Saitama Medical University, Moroyama, Japan.

Abstract

Diabetes mellitus constitutes a major disease burden globally, and the prevalence of diabetes continues to increase worldwide. We aimed to estimate the burden of cancer associated with type 2 diabetes mellitus in Japan between 2010 and 2030. In this study, we estimated the population attributable fraction of cancer risk associated with type 2 diabetes in 2010 and 2030 using the prevalence estimates of type 2 diabetes in Japan from 1990 to 2030, summary hazard ratios of diabetes and cancer risk from a pooled analysis of eight large-scale Japanese cohort studies, observed incidence/mortality of cancer in 2010 and predicted incidence/mortality for 2030 derived from the age-period-cohort model. Our results showed that between 2010 and 2030, the total numbers of cancer incidence and mortality were predicted to increase by 38.9% and 10.5% in adults aged above 20 years, respectively. In the number of excess incident cancer cases associated with type 2 diabetes, an increase of 26.5% in men and 53.2% in women is expected between 2010 and 2030. The age-specific analysis showed that the population attributable fraction of cancer will increase in adults aged >60 years over time, but will not change in adults aged 20-59 years. In conclusion, this study suggests a modest but steady increase in cancers associated with type 2 diabetes.

KEYWORDS:

APC models; cancer; diabetes mellitus; population attributable fraction; prediction

PMID:
27079439
PMCID:
PMC4832854
DOI:
10.1111/cas.12902
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center